Item 5 Report to Board, 25 July 2017 Report title Chief executive s report Report from David Probert, chief executive Prepared by David Probert and the executive team Previously discussed at Management Executive Attachments Brief summary of report The report covers the following areas; CQC action plan progress update Information governance Patient Safety Award 2017 Operational performance Month 3 performance People Education Strategy Research Action required/recommendation. The board is asked to note the chief executive s report. For assurance For decision For discussion To note 1 of 5
1. Quality and safety MOORFIELDS EYE HOSPITAL NHS FOUNDATION TRUST CQC action plan progress update PUBLIC BOARD MEETING 26 July 2017 Chief Executive s report Due to the timings of management executive meetings and the Trust Board, the latest progress update of the CQC action plan is the one that went to the June Board. However progress monitoring continues between formal review and our plan remains on target. We are now more than half way through completion of the plan. Ongoing monitoring indicates that, as of 1 July, 28 actions (from a total of 50) have now been completed. The following table shows the completion schedule: Action completion dates Target Actual Actions completed by 14.03.17 11 (22%) 11 Actions completed by 31.03.17 21 (42%) 17 Actions completed by 30.06.17 32 (64%) 2 of 5 28 (56%) completed as at 01/07/2017* [*4 actions still to be reported] Actions completed by 30.09.17 45 (90%) - Actions completed by 31.12.17 48 (96%) - Actions completed after 01.01.2018 50 (100%) - Four areas of concern have been previously reported at management executive including completion of all the service level agreements (SLAs), where good progress has been made, although some areas remain outstanding. There are also delays in planning for the St George s major theatre and ward improvements, but I and colleagues are actively involved in revising the plans. The next CQC update will come to the September meeting of the board. Information governance Google DeepMind The board will be aware of the collaboration that the trust is involved in with Google DeepMind and I wanted to assure the board that the recent case involving Google and the Royal Free does not apply to the trust. The details are shown below; On 3 July 2017, the Information Commissioner s Office (ICO) determined that the processing of approximately 1.6 million Royal Free NHS Trust patient personal identifiable records by DeepMind for the purpose of clinical safety testing of an application, did not fully comply with the requirements of the Data Protection Act 1998. The Moorfields DeepMind collaboration involves the sharing of anonymised digital eye scans and the Trust rigorously ensures that no personally identifiable data is included in the database of scans which is provided to DeepMind. The anonymisation procedures were thoroughly validated and formally approved by the Trust s information governance team before the data transfer with DeepMind was established. When researchers are working with anonymised data and with no way of identifying individual patients, explicit consent from patients for their data to be used in this way is not required. This is in line with the ICO S anonymisation code of conduct. Additionally, it was agreed that DeepMind takes rigorous measures to protect the security of the data, and avoid disclosing it to anyone other than the researchers and engineers working
on the project. Data contributing to this study can only be used for research that explores the use of machine learning to support clinicians in their management and diagnosis of eye diseases. The data itself cannot be linked with any other dataset, although any new models or software produced by the research may be linked to other datasets to allow for it to be used to help treat patients in the future, and also to enable further research to improve the models by drawing upon other approved sources of data. Patient Safety Award 2017 This month Emily Cabourne, specialist registrar, attended the 2017 Patient Safety Awards in Manchester. Emily s submission, Optimising patient outcomes following routine cataract surgery; lessons learnt from an unexpected case series of adverse events, was awarded first prize in the clinical governance and risk management in patient safety category. Congratulations to Emily and the team. 2. Operational Operational performance The Trust continues to perform well on operational targets overall although there are key challenges in some areas. Further details will be provided by the chief operating officer as part of the integrated performance report. In the south at the Queen Mary s, Roehampton (QMR) site there has been a recent issue identified with the CliniComm system provided by St Georges. This has led to some St Georges patients being discharged when they should not have been. At QMR we run services for our patients and these are not affected. There are, however, St Georges ophthalmology patients on their systems which we help manage. We are working with St Georges to support them through this period and identify and treat any patients that may have been incorrectly discharged from this system. Guidance for winter resilience this year has been received from NHS Improvement and NHS England. Although much of the guidance is more relevant to acute trusts there are key issues we will have to implement. Rapid access triaging is a key element of this which supports our existing strategy of active triage by our nurses. Our Cayton Street project will be a key enabler in supporting this guidance. The City Road division, supported by the service improvement team, will ensure that this guidance is embedded in our processes. 3. Financial Month 3 performance The Trust performed well in month 3 allowing us to exceed our plan and achieve a risk rating of 1 for the quarter. Further details will be provided by the chief finance officer as part of the finance report agenda item. Guidance for the 2017/18 sustainability and transformation fund was received from NHS Improvement earlier in the month. Receipt of all of our core 0.9 million allocation for the year will depend on meeting our financial target, a change from the previous year where 30% was dependent upon our meeting national access standards. In addition, it was confirmed that 15% of the funding will be allocated in quarter 1, 20% in quarter 2, 30% in quarter 3 and 35% in quarter 4. This is in line with our plan phasing. Finally, the guidance detailed that 200 million of the national fund remains unallocated
4. People Recruitment Mr Anthony Khawaja, who is currently a fellow at Moorfields, has been appointed as a consultant ophthalmic surgeon, specialising in glaucoma and research (epidemiology, genetics and big data). He is expected to take up his position in August. External appointments and awards Congratulations to Parul Desai, consultant in public health and ophthalmology, who has been appointed chair of the Clinical Council for Eye Health Commissioning (CCHEC). The CCHEC brings together the leading professional, patient and representative bodies involved in eye health, providing collective expertise to commissioners, providers, clinicians and policy-makers on the commissioning of eye health services in England. 5. Education It was my pleasure to present at the inaugural educators conference held at the Institute of ophthalmology on the 3 July 2017. The event, attended by colleagues form the trust and the institute, focussed on undergraduate and post graduate education and learning from various professional groups as well as UCL and St George s medical schools and the London Deanery, school of ophthalmology. The programme encompassed presentations on innovations in teaching methods for undergraduates and the importance of learner professionalism such as attitudes and personal responsibility, to inspirational patient involvement initiatives such as design your eye doctor day. Evaluation from the conference was positive and I look forward to future events. 6. Strategy The trust's refreshed five-year strategy 'Vision of Excellence' brings together all aspects of our work across clinical care, research and education. It applies to our NHS and private services, both in the UK and internationally and sets out our core belief 'people's sight matters'. Our purpose is 'working together to discover, develop and deliver the best eye care'. The refreshed strategy was launched internally on 6 July. Three briefing sessions were held at City Road which were attended by approximately 200 staff. A programme of strategy roadshows across the network is planned over the coming months - sessions have already been held in Dubai and Ealing. The strategy was launched externally on 11 July at an event attended by many of the external stakeholders who were involved in the strategy development. The news of the strategy launch has been picked up across our social media channels and in the trade press. Empowering local teams and leaders to deliver change will be critical if the strategy is to be successfully implemented. The executive team will continue working with colleagues across the organisation to ensure they understand what the strategy means for them and to support them in driving improvements. 7. Research Our orbital consultants, Geoff Rose and David Verity, in collaboration with neurologist colleagues at UCL and the University of Oxford, and consultants Gill Adams and Maria Theodorou have reported the results of the world s first human implantation of magnets behind a person s eyes to treat nystagmus, a condition which causes involuntary eye movements. Nystagmus, sometimes called dancing eyes', affects close to one in 400 people and can cause reduced visual acuity. There is now a larger study underway funded by the National Institute for Health Research Invention 4 Innovation (i4i) scheme.
David Probert Chief Executive 18 July 2017